Recent News & Comments About drug loss weight
Weight-loss drug Lorcaserin: Definite maybe in 2nd run at FDA's OK
The proposed weight-loss drug Lorcaserin, rebuffed in its bid for Food and Drug Administration approval last October, on Thursday won a recommendation of approval from the agency's advisory committee, a major step toward winning the FDA's go-ahead to enter the U.S. market. If the agency follows the advice of the panel of independent experts--which is common but not routine-- Lorcaserin would ...
FDA advisers recommend approving weight loss drug
Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.
New Weight-Loss Drug Shows Promise in Trial
THURSDAY, May 10 (HealthDay News) -- A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researchers report.
Arena and Orexigen Compete to Bring First Weight Loss Drug to Market in Nearly 13 Years
NEW YORK, NY-- - Biotech companies are looking to cash in on the anti-obesity drug market. The race to bring the first weight-loss pill to the market is heating up as Arena Pharmaceuticals weight-loss ...
FDA Panel Gives Blessing to New Weight-Loss Drug
THURSDAY, May 10 (HealthDay News) -- An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects.
FDA Advisory Panel Recommends Approval For Weight Loss Drug Lorcaserin
The FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted to recommend approval of lorcaserin (Lorqess, Arena). The result signals a remarkable turnaround for the drug, which the same panel had rejected in September 2010. The vote was 18 in favor of approval, 4 against, and 1 abstention.
FDA advisers recommend OK for weight loss drug
Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks. Shares of the drug’s creator, Arena Pharmaceuticals Inc., nearly doubled, jumping from $3.66 to $7.15 in after-hours trading after trading was [...]
FDA Panel Gives Blessing to New Weight-Loss Drug Lorcaserin
If agency follows suit, lorcaserin could be first such medication approved in a decade
Lorcaserin weight loss drug wins thumbs up from FDA panel
SILVER SPRING, Md. -- For the second time in less than three months, an expert panel convened by the US Food and Drug Administration voted to recommend approval of a prescription weight loss drug that had previously been rejected because of safety concerns: Lorcaserin (Lorqess) was approved Thursday by an 18 to 4 vote with 1 abstention for its ability to help overweight people shed pounds with ...
Arena Weight-Loss Drug Wins Over FDA Advisers
An experimental obesity pill from Arena Pharmaceuticals won the support of U.S. advisers on Thursday, as public health advocates push for new solutions to the nation's growing obesity epidemic.
 |
|
Free Diet Articles
|
